Menu
HDL Mediated Cholesterol Transport Part 3

HDL Mediated Cholesterol …

The HDL Biogenesis s...

 Commentary on "The Death of Fish Oil?, the Risk and Prevention Study"

Commentary on "The …

The Death of Fish...

Beyond Glycemia:  Cardiovascular and Mortality Benefits of Metformin

Beyond Glycemia: Cardiov…

Background Cardio...

The Elephant in the Exam Room: How Insurance Companies Affect the Doctor-Patient Relationship

The Elephant in the Exam …

I had a moment of sa...

Response to "Lipid-Related Markers and Cardiovascular Disease Prediction"

Response to "Lipid-R…

First Response (S...

Basics Of Lipid Trafficking Part 1

Basics Of Lipid Trafficki…

This interactive pr...

Sweet and Low BP Effects of antidiabetes meds- part 2

Sweet and Low BP Effects …

This lecture will...

How many cholesterol molecules are there in an LDL

How many cholesterol mole…

This short progra...

Second Response to "Lipid-Related Markers and Cardiovascular Disease Prediction"

Second Response to "…

Second Response ...

Prev Next
Good for statin, but better for statin + ezetimibe!

Good for statin, but better for statin + ezetimibe!

Author: Thomas Dayspring MD, FACP, FNLA, NCMP Published: November 2014 (see also: IMProved Reduction of Outcomes)  To paraphrase the late President Gerald Ford who once said, “Myfellow Americans,  our long national nig...

Latest Lectures

Vitamin D: Merging Research into a Clinical Lipid Practice

Vitamin D: Merging Research …

Skeletal effects of low vitamin D have been recognized for a long time. Howev...

Part 2: The Triglyceride/HDL Axis

Part 2: The Triglyceride/HDL…

Part 2 of 3: The Objectives of this program titled "The Triglyceride/HDL...

Benefit of Eating Fish in Women with CVD risk

Benefit of Eating Fish in Wo…

Dr Marin Strom, from the Statens Serum Institute, Copenhagen, Denmark, reported ...

IMProved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE IT): Design and Baseline Data [1 of 2]

IMProved Reduction of Outcom…

►►A multicenter, randomized, double-blind, active-control trial designed...

More Lectures!